Helus Pharma Names Mark Lawson Independent Board Chair

• Helus Pharma co-founder Eric So stepped down as president and executive chairman.
• Co-founder Paul Glavine stepped down as chief growth officer.
• Mark Lawson became independent board chair, effective immediately; his background includes over 20 years in private equity and investment banking.
• So was named chairman emeritus, an honorary title.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270800PRIMZONEFULLFEED9853636) on October 27, 2026, and is solely responsible for the information contained therein.